Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Nov 18, 2014; 5(5): 645-652
Published online Nov 18, 2014. doi: 10.5312/wjo.v5.i5.645
Published online Nov 18, 2014. doi: 10.5312/wjo.v5.i5.645
Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes
Antonella Mameli, Internal Medicine and Haemocoagulopathies Division, AOU of Monserrato (Ca), 09042 Monserrato, Italy
Francesco Marongiu, Internal Medicine and Haemocoagulopathies Division, University of Cagliari, 09123 Cagliari, Italy
Author contributions: Mameli A and Marongiu F contributed equally to this work.
Correspondence to: Antonella Mameli, MD, Internal Medicine and Haemocoagulopathies Division, AOU of Monserrato (Ca), SS 554, 09042 Monserrato, Italy. amameli@medicina.unica.it
Telephone: +39-070-6754188 Fax: +39-070-51096201
Received: December 25, 2013
Revised: March 26, 2014
Accepted: May 28, 2014
Published online: November 18, 2014
Processing time: 238 Days and 18.6 Hours
Revised: March 26, 2014
Accepted: May 28, 2014
Published online: November 18, 2014
Processing time: 238 Days and 18.6 Hours
Core Tip
Core tip: The purpose of this review is to quantify the incidence of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA) undergoing major orthopedic surgery and to discuss the current management of VTE prophylaxis in RA patients undergoing major joint arthroplasty and establish whether these patients are at higher risk for VTE than the general population.